M&A TRANSACTION · 2022
Osteogenics Biomedical Inc. (Allotech and OBI Biologics) acquired by Envista Holdings Corp.
$126.1M· 4.20x revenue
Target
Osteogenics Biomedical Inc. (Allotech and OBI Biologics)
Acquirer
Envista Holdings Corp.
Strategic buyer
Disclosed financials at time of acquisition
Revenue
$30.0M
EBITDA
—
Deal Value
$126.1M
EV/EBITDA
—
Context
This $126.1M acquisition of Osteogenics Biomedical Inc. (Allotech and OBI Biologics) by Envista Holdings Corp. sits in the dental practice sub-vertical. Envista Holdings Corp. is acquiring as a strategic buyer; see how strategic acquirers typically price dental practice businesses on our Dental Practice strategic buyer-pool page.
Source
Data sourced from SEC filings and press releases. All figures reflect disclosed values at the time of the acquisition; no estimated or imputed data. Methodology
Value your own dental practice
Get an instant valuation range for your business. Backed by 25,592 real M&A transactions.
Compare your business to the Osteogenics Biomedical Inc. (Allotech and OBI Biologics) acquisition.